PremiumNew Delhi: The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their COVID-19 vaccines amid criticism from various states who objected to profiteering during such a major crisis.
The issue of vaccine pricing was discussed at a meeting chaired by Cabinet Secretary Rajiv Gauba.
Premium Now the two companies are expected to come up with revised pricing for their vaccines.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at ₹600 per dose for state governments and at ₹1,200 per dose for private hospitals.
The Pune-based Serum Institute of India (SII), the world's largest vaccine maker in terms of volume, has announced a price of ₹400 per dose for its COVID-19 vaccine, 'Covishield', for state governments and ₹600 per dose for private hospitals.
Both vaccines are available to the central government at a rate of ₹150 per dose.
Many states have objected to different prices of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this is not time for profiteering.
India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to get inoculated from May 1.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.
Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.
